31 – 40 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
mHTT Seeding Activity : A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
-
Mark
Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay
(
- Contribution to journal › Article
-
Mark
Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
-
Mark
Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage
(
- Contribution to journal › Article
- 2016
-
Mark
Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Ethical aspects of a predictive test for Huntington's Disease: A long term perspective.
(
- Contribution to journal › Article